These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15133780)

  • 21. Characteristics of good causation studies.
    Daya S
    Semin Reprod Med; 2003 Feb; 21(1):73-83. PubMed ID: 12806562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials.
    Janicak PG; Wu JH; Mao L
    Curr Med Res Opin; 2008 Jun; 24(6):1807-15. PubMed ID: 18559166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strengthening the case for disease management effectiveness: un-hiding the hidden bias.
    Linden A; Adams JL; Roberts N
    J Eval Clin Pract; 2006 Apr; 12(2):140-7. PubMed ID: 16579822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
    Holme I; Szarek M; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):315-20. PubMed ID: 19322096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing randomized phase II trials assessing tumor progression.
    Stone A; Wheeler C; Carroll K; Barge A
    Contemp Clin Trials; 2007 Feb; 28(2):146-52. PubMed ID: 16807129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ensuring the comparability of comparison groups: is randomization enough?
    Berger VW; Weinstein S
    Control Clin Trials; 2004 Oct; 25(5):515-24. PubMed ID: 15465620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common problems related to the use of number needed to treat.
    Stang A; Poole C; Bender R
    J Clin Epidemiol; 2010 Aug; 63(8):820-5. PubMed ID: 19880287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive truncated weighting for improving marginal structural model estimation of treatment effects informally censored by subsequent therapy.
    Bai X; Liu J; Li L; Faries D
    Pharm Stat; 2015; 14(6):448-54. PubMed ID: 26436533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety assessment in radomized controlled clinical trials].
    Liu Y; Yao C; Chen F; Zhang G; Xia J; Chen Q; Su B
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):74-9. PubMed ID: 14979215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What random assignment does and does not do.
    Krause MS; Howard KI
    J Clin Psychol; 2003 Jul; 59(7):751-66. PubMed ID: 12808582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sources of bias in clinical trials.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):595-6. PubMed ID: 21967950
    [No Abstract]   [Full Text] [Related]  

  • 40. [Randomization and alternatives].
    Olsen J; Olesen C
    Ugeskr Laeger; 1999 May; 161(18):2657-60. PubMed ID: 10434785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.